The ABPI has responded to the Prime Minister’s comments on the possibility of a ‘no deal’ Brexit.
The Prime Minister said that the UK must prepare for a ‘no deal’, while also indicating that the negotiations between the EU the UK will continue.
Richard Torbett, Chief Executive of the ABPI has said in response that:
“No deal is not in the interest of patients, the pharmaceutical industry, or the economies of the UK and the EU. As long as a window of opportunity remains, negotiators must keep talking and agree a comprehensive deal.
“They must ensure medicines supplies are uninterrupted and that a way forward for patients in Northern Ireland is urgently found.
“Our members are preparing for the end of the transition period at the same time as coronavirus cases rise across Europe. This should be enough to focus minds.”
Read the ABPI article for more details.